ea0086p67 | Metabolism, Obesity and Diabetes | SFEBES2022
Nagarajan Shilpa
, Cross Eloise
, Johnson Elspeth
, Westcott Felix
, Hodson Leanne
Background: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of diseases starting with pathological accumulation of intrahepatocellular triglyceride (TG) (i.e. steatosis), which can progress to steatohepatitis (NASH) and cirrhosis. Insulin resistance is often associated with the development of steatosis and disease progression however, the underlying mechanisms for this are poorly defined. A major challenge in modelling human NAFLD disease progression is the la...